By Josh White
Date: Thursday 14 Aug 2025
(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to between £4.5m and £4.8m, driven by a full-year contribution from Dermatonics, eight months from Bio-Tech Solutions (BTS), and continued organic growth in AxisBiotix sales.
By Josh White
Date: Monday 16 Jun 2025
(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.
By Benjamin Chiou
Date: Friday 11 Oct 2024
(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.
| Currency | UK Pounds |
| Share Price | 15.88p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 26.10p |
| 52 Week Low | 13.63p |
| Volume | 714,589 |
| Shares Issued | 258.78m |
| Market Cap | £41.08m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:18 | 500,000 @ 16.25p |
| 11:42 | 15,000 @ 15.81p |
| 11:28 | 1,329 @ 16.24p |
| 10:53 | 6 @ 16.24p |
| 10:50 | 63,337 @ 15.81p |
| CEO | Stuart Ashman |
| CFO | Manprit Singh Randhawa |
You are here: research